menu
    • menu

    Company profile for Onyx Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Onyx Pharmaceuticals, Inc., an Amgen subsidiary, strives for the highest standards of business conduct and ethics. Our Code of Conduct and the Onyx Values reflect the business practices and principles of behavior that support this commitment. We are dedicated to creating a culture that encourages responsible corporate action at every level in our organization. It is expected that all officers, employees, and agents of Onyx wil...
    Onyx Pharmaceuticals, Inc., an Amgen subsidiary, strives for the highest standards of business conduct and ethics. Our Code of Conduct and the Onyx Values reflect the business practices and principles of behavior that support this commitment. We are dedicated to creating a culture that encourages responsible corporate action at every level in our organization. It is expected that all officers, employees, and agents of Onyx will maintain the standards established in our Code of Conduct, adhere to the policies created in support of the code, and embrace the spirit of our Onyx Values.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Onyx PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    249 E. Grand Avenue South, San Francisco, CA 94080
    Telephone
    Telephone
    +1 650.266.0000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.onyx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amgen Wins Ruling on Patents for Kyprolis Cancer Drug
    Amgen Wins Ruling on Patents for Kyprolis Cancer Drug

    05 May 2020

    // Christopher Yasiejko BLOOMBERG

    https://www.bloomberg.com/news/articles/2020-05-05/amgen-wins-ruling-on-patents-for-kyprolis-cancer-drug

    Christopher Yasiejko BLOOMBERG
    05 May 2020
    Share Share
    After exiting troubled Merrimack, former CEO becomes new chief at Yumanity
    After exiting troubled Merrimack, former CEO becomes new chief at Yumanity

    10 Jul 2019

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/after-exiting-troubled-merrimack-former-ceo-becomes-new-chief-at-yumanity

    Ben Adams FIERCE BIOTECH
    10 Jul 2019
    Share Share
    Natco, Onyx settle cancer drug patent litigation
    Natco, Onyx settle cancer drug patent litigation

    01 Jun 2019

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-onyx-settle-cancer-drug-patent-litigation/articleshow/69591844.cms

    ECONOMIC TIMES
    01 Jun 2019
    Share Share
    Natco settles patent dispute with Onyx for blood cancer drug Carfilzomib
    Natco settles patent dispute with Onyx for blood cancer drug Carfilzomib

    31 May 2019

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/natco-settles-patent-dispute-with-onyx-therapeutics-for-blood-cancer-drug-carfilzomib-4043701.html

    MONEYCONTROL
    31 May 2019
    Share Share
    Natco, Onyx settle cancer drug patent litigation
    Natco, Onyx settle cancer drug patent litigation

    30 May 2019

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-onyx-settle-cancer-drug-patent-litigation/articleshow/69591844.cms

    ECONOMIC TIMES
    30 May 2019
    Share Share
    Cerdelga (eliglustat): Genzyme vs. Dr. Reddy’s Labs
    Cerdelga (eliglustat): Genzyme vs. Dr. Reddy’s Labs

    24 Nov 2018

    // PATENT LITIGATION

    https://insight.rpxcorp.com/litigation_documents/13149171

    PATENT LITIGATION
    24 Nov 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search